Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

CIDRZ Zambia ART program cost-effectiveness in 45 sites.

Domaine:

healthcare

Type de record:

dataset
Créateur:
EllMarAlbAng
Hôte:avatar

Cost effectiveness is presented as costs and mortality reductions following initial 16 weeks of therapy; and for the entire period between ART services initiation at each site and July 1, 2008. Means are the sum of all DALYs or deaths averted across all sites, divided by the sum of the costs at all sites. Standard deviations are calculated for the mean values of all sites.

Visit

figshare.com

Tags

MedicineInfectious Diseaseszambiacost-effectiveness45

Licenses

CC BY 4.0

Similaires

<p>Program cost-effectiveness.</p>Google + CIDRZ Health AI Evaluation ZambiaBreakdown of per patient costs by cost item during the first year on treatment at six ART treatment sites in Zambia.A health benefit and cost-effectiveness analysis of pneumococcal conjugate vaccination program in NigeriaReaching the First 90%: Cost-effectiveness of HIV self testing services in ZambiaCosts and cost-effectiveness of a comprehensive tuberculosis case finding strategy in Zambia

<p>Program cost-effectiveness.</p>

The Sepsis Prevention in Neonates in Zambia (SPINZ) trial was a prospective observational co

Google + CIDRZ Health AI Evaluation Zambia

Validation of Google Artificial Intelligence Enabled TB Screening and Diagnosis

Breakdown of per patient costs by cost item during the first year on treatment at six ART treatment sites in Zambia.

ART: antiretroviral therapy; ARV: antiretroviral; USD: United States dollar.

a

Outpatient vi

A health benefit and cost-effectiveness analysis of pneumococcal conjugate vaccination program in Nigeria

Background: Nigeria ranks third just behind India and China in the global disease burden of pneumoco

Reaching the First 90%: Cost-effectiveness of HIV self testing services in Zambia

Adult HIV prevalence in Zambia is approximately 12%, and an estimated 28% of people living with HIV

Costs and cost-effectiveness of a comprehensive tuberculosis case finding strategy in Zambia

Introduction Active-case finding (ACF) programs have an important role in addressing case detectio